Potential values of circulating tumor cell for detection of recurrence in patients of thyroid cancer: a diagnostic meta-analysis.
Ming-Xing LiangYin-Jiao FeiKai YangWen-Juan TangXin-Hui CaoJin-Hai TangPublished in: BMC cancer (2022)
CTC was a reliable marker for the diagnosis of TC patients with recurrence and DMs, and the sensitivity of CTCs expressing TSHR was higher than that of EpCAM. Additional research is warranted in order to establish uniformity in international guidelines, make up the drawbacks of conventional diagnostic methods and to prevent futile surgery.
Keyphrases
- circulating tumor cells
- circulating tumor
- systematic review
- end stage renal disease
- newly diagnosed
- minimally invasive
- ejection fraction
- peritoneal dialysis
- single cell
- free survival
- prognostic factors
- coronary artery bypass
- stem cells
- cell therapy
- randomized controlled trial
- risk assessment
- patient reported outcomes
- acute coronary syndrome
- mesenchymal stem cells
- atrial fibrillation
- loop mediated isothermal amplification
- quantum dots